Pall Corp-医療機器分野:企業M&A・提携分析

◆英語タイトル:Pall Corp - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011087
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pall Corp (Pall), a subsidiary of Danaher Corporation, is a supplier of filtration, separation and purification products and technologies to remove solid, liquid and gaseous contaminants from liquids and gases. Its major products include biochemicals, bioreactors, breathers, canisters, cartridges and elements, centrifugal devices, cleaners, coalescers, filter funnels and housings, filter plates, membranes and materials, microcarriers, mixers, modules, point-of-use filters, purifiers, respiratory and anesthesia products, sterilizable packaging, syringe filters and testing and monitoring products. The company’s products are used in medical, biopharmaceuticals, food and beverage, energy and water, aerospace, defense, marine and microelectronics markets. The company sells its products through direct offices and a network of distributors in Europe, Americas and Asia. Pall is headquartered in Port Washington, New York, the US.

Pall Corp – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pall Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Pall Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Pall Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Pall Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Pall Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Pall Corp, Medical Equipment, Deal Details 10
Asset Transactions 10
Haemonetics Completes Acquisition Of Blood Collection, Filtration And Processing Product Lines From Pall For US$551 Million 10
Acquisition 12
Danaher Acquires Pall for USD13.8 Billion 12
Pall Corporation Completes Acquisition Of ForteBio For US$142.5 Million 14
Pall Corp – Key Competitors 16
Pall Corp – Key Employees 17
Pall Corp – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 23
Product News 23
Jul 27, 2017: Pall Corporation Introduces Proprietary Bioreactor Control System 23
Oct 04, 2016: Pall Life Sciences Extends the Range of Continuous, Single-Use Technologies To Improve Speed and Quality of Biopharmaceutical Production 24
Other Significant Developments 26
Nov 21, 2017: New Stax mAx Clarification Platform from Pall Life Sciences Delivers Robust, Accelerated Performance Across Multiple mAb Processes 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Pall Corp, Medical Equipment, Key Facts, 2014 2
Pall Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Pall Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Pall Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Pall Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Pall Corp, Deals By Market, 2011 to YTD 2017 8
Pall Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Haemonetics Completes Acquisition Of Blood Collection, Filtration And Processing Product Lines From Pall For US$551 Million 10
Danaher Acquires Pall for USD13.8 Billion 12
Pall Corporation Completes Acquisition Of ForteBio For US$142.5 Million 14
Pall Corp, Key Competitors 16
Pall Corp, Key Employees 17
Pall Corp, Other Locations 18
Pall Corp, Subsidiaries 20

★海外企業調査レポート[Pall Corp-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Raya Holding (RAYA):企業の財務・戦略的SWOT分析
    Raya Holding (RAYA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Independence Group NL:企業のM&A・事業提携・投資動向
    Independence Group NL - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Independence Group NL Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Great Western Bancorp Inc:企業の戦略・SWOT・財務分析
    Great Western Bancorp Inc - Strategy, SWOT and Corporate Finance Report Summary Great Western Bancorp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Driver Group Plc (DRV):企業の財務・戦略的SWOT分析
    Driver Group Plc (DRV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Torii Pharmaceutical Co Ltd (4551)-製薬・医療分野:企業M&A・提携分析
    Summary Torii Pharmaceutical Co Ltd (Torii) a subsidiary of Japan Tobacco Inc is a healthcare product provider that manufactures and markets products such as antebate ointment, antebate cream and urinorm used for the treatment of hyperuricemia and gout. The company offers products for the treatment …
  • Energias de Portugal S.A:企業の戦略・SWOT・財務分析
    Energias de Portugal S.A - Strategy, SWOT and Corporate Finance Report Summary Energias de Portugal S.A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Nobel Biocare Services AG:企業の戦略的SWOT分析
    Nobel Biocare Services AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Heineken NV:企業のM&A・事業提携・投資動向
    Heineken NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Heineken NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Presidio Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Presidio Pharmaceuticals Inc (Presidio Pharmaceuticals) is a clinical-stage pharmaceutical company that discovers, develops, and supplies small-molecule antiviral therapeutics. The company’s products include HCV NS5A, protease inhibitor, ravidasvir hydrochloride, NS5B proteins, lead pan-geno …
  • Bureau Veritas SA:企業のM&A・事業提携・投資動向
    Bureau Veritas SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bureau Veritas SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • SK Chemicals Co Ltd (006120):企業の財務・戦略的SWOT分析
    Summary SK Chemicals Co Ltd (SK Chemicals) is a chemical company that provides life sciences products and solutions. The company manufactures polyester and acetate yarns for textile, and industrial uses. Its copolyesters comprise ecozen, skygreen and skypets. SK Chemicals provides high-performance r …
  • Siemens AG (SIE):企業の財務・戦略的SWOT分析
    Siemens AG (SIE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Symrise AG (SY1):製薬・医療:M&Aディール及び事業提携情報
    Summary Symrise AG (Symrise) offers flavors and fragrances. The company develops, produces and sells flavorings, fragrances, cosmetic active ingredients and raw materials, and functional ingredients and solutions for the cosmetics industry. It also provides biofunctional and bioactive ingredients an …
  • GW Pharmaceuticals Plc (GWP)-製薬・医療分野:企業M&A・提携分析
    Summary GW Pharmaceuticals plc (GW Pharmaceuticals) is a biopharmaceutical company which discovers, develops and commercializes innovative therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, f …
  • Nexstim Plc (NXTMH):医療機器:M&Aディール及び事業提携情報
    Summary Nexstim Plc (Nexstim) focuses on navigated, non-invasive brain stimulation therapy and diagnosis based on E-field navigated neuro stimulation technology (eTMS). Its NBS system applies the technology for pre-surgical mapping of the motor and speech cortices. It is also used for research, ther …
  • Maxar Technologies Ltd (MAXR):企業の財務・戦略的SWOT分析
    Maxar Technologies Ltd (MAXR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Motor Oil (Hellas) Corinth Refineries SA (MOH):石油・ガス:M&Aディール及び事業提携情報
    Summary Motor Oil (Hellas) Corinth Refineries SA (MOH) is an independent oil refining company. It produces and markets petroleum products, which include gasoline, diesel, fuel oil, asphalt, jet fuel, lubricants and others. MOH operates refinery complex in Corinth, which includes crude distillation u …
  • Reckitt Benckiser Group plc:企業のM&A・事業提携・投資動向
    Reckitt Benckiser Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Reckitt Benckiser Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Infineum International Ltd:企業の戦略的SWOT分析
    Infineum International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Blonder Tongue Laboratories, Inc. (BDR):企業の財務・戦略的SWOT分析
    Blonder Tongue Laboratories, Inc. (BDR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆